Clinical Trial Update: ROMEO (Rosuvastatin in Metabolic syndrOme) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rosuvastatin in metabolic syndrome (Metabolic Syndrome X) has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Metabolic Syndrome X | Phase 4 | Status: COMPLETED | Results posted: 2011-06-16